lobbying_activities: 920316

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
920316	0a50872f-3979-48c6-9ada-d02bfe81f1e4	Q1	AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	3457	AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	2010	first_quarter	PHA	Communication with FDA regarding the quality of compounded drugs and improving stakeholder communications; Communications to the Agency for Healthcare Research and Quality regarding nominations to Effective Healthcare Stakeholder Group; Communication with FDA on Risk Evaluation and Mitigation Strategies and Prescription Drug User Fee Act Reauthorization Public Meeting.	Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		250000	0	0	2010-04-19T11:07:43.413000-04:00